Works by Okamoto, Wataru

Results: 52
    1

    Trajectory for the Regulatory Approval of a Combination of Pertuzumab Plus Trastuzumab for Pre-treated HER2-positive Metastatic Colorectal Cancer Using Real-world Data.

    Published in:
    2023
    By:
    • Yasutoshi Sakamoto;
    • Hideaki Bando;
    • Yoshiaki Nakamura;
    • Hiromi Hasegawa;
    • Takako Kuwaki;
    • Wataru Okamoto;
    • Hiroya Taniguchi;
    • Yoshihiro Aoyagi;
    • Izumi Miki;
    • Hiroshi Uchigata;
    • Naomi Kuramoto;
    • Nozomu Fuse;
    • Takayuki Yoshino;
    • Atsushi Ohtsu;
    • Sakamoto, Yasutoshi;
    • Bando, Hideaki;
    • Nakamura, Yoshiaki;
    • Hasegawa, Hiromi;
    • Kuwaki, Takako;
    • Okamoto, Wataru
    Publication type:
    journal article
    2
    3

    Polyoxazoline-conjugated porcine serum albumin as an artificial plasma expander for dogs.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-35999-4
    By:
    • Okamoto, Wataru;
    • Usui, Tomone;
    • Hasegawa, Mai;
    • Kobayashi, Tatsuhiro;
    • Fujisawa, Junya;
    • Taguchi, Kazuaki;
    • Matsumoto, Kazuaki;
    • Kohno, Mitsutomo;
    • Iwazaki, Masayuki;
    • Shimano, Shotaro;
    • Nagao, Itsuma;
    • Toyoda, Hiroto;
    • Matsumura, Naoki;
    • Tomiyasu, Hirotaka;
    • Tochinai, Ryota;
    • Komatsu, Teruyuki
    Publication type:
    Article
    4

    Comprehensive genomic profiling testing in Japanese castration-resistant prostate cancer patients: results of a single-center retrospective cohort study.

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 2, p. 175, doi. 10.1093/jjco/hyad148
    By:
    • Fukushima, Takafumi;
    • Goto, Keisuke;
    • Hayashi, Tetsutaro;
    • Ikeda, Kenichiro;
    • Hatayama, Tomoya;
    • Yamanaka, Ryoken;
    • Iwane, Kyosuke;
    • Tasaka, Ryo;
    • Kohada, Yuki;
    • Takemoto, Kenshiro;
    • Kobatake, Kohei;
    • Goriki, Akihiro;
    • Toshida, Asuka;
    • Nakahara, Hikaru;
    • Motonaga, Masanori;
    • Tokumo, Kentaro;
    • Fujii, Yasutoshi;
    • Hayes, C Nelson;
    • Okamoto, Wataru;
    • Kubo, Toshio
    Publication type:
    Article
    5
    6

    Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab Treatment.

    Published in:
    Cancers, 2023, v. 15, n. 17, p. 4234, doi. 10.3390/cancers15174234
    By:
    • Tamura, Yosuke;
    • Ono, Atsushi;
    • Nakahara, Hikaru;
    • Hayes, Clair Nelson;
    • Fujii, Yasutoshi;
    • Zhang, Peiyi;
    • Yamauchi, Masami;
    • Uchikawa, Shinsuke;
    • Teraoka, Yuji;
    • Uchida, Takuro;
    • Fujino, Hatsue;
    • Nakahara, Takashi;
    • Murakami, Eisuke;
    • Tsuge, Masataka;
    • Serikawa, Masahiro;
    • Miki, Daiki;
    • Kawaoka, Tomokazu;
    • Okamoto, Wataru;
    • Imamura, Michio;
    • Nakamura, Yuko
    Publication type:
    Article
    7

    Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-Fetoprotein.

    Published in:
    Cancers, 2023, v. 15, n. 8, p. 2304, doi. 10.3390/cancers15082304
    By:
    • Kinami, Takahiro;
    • Amioka, Kei;
    • Kawaoka, Tomokazu;
    • Uchikawa, Shinsuke;
    • Yamasaki, Shintaro;
    • Kosaka, Masanari;
    • Johira, Yusuke;
    • Yano, Shigeki;
    • Naruto, Kensuke;
    • Ando, Yuwa;
    • Yamaoka, Kenji;
    • Fujii, Yasutoshi;
    • Fujino, Hatsue;
    • Nakahara, Takashi;
    • Ono, Atsushi;
    • Murakami, Eisuke;
    • Okamoto, Wataru;
    • Yamauchi, Masami;
    • Miki, Daiki;
    • Tsuge, Masataka
    Publication type:
    Article
    8

    Effectiveness of Repeated Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma—Consideration of the Locations of Target Lesions.

    Published in:
    Cancers, 2023, v. 15, n. 3, p. 846, doi. 10.3390/cancers15030846
    By:
    • Yano, Shigeki;
    • Kimura, Tomoki;
    • Kawaoka, Tomokazu;
    • Kinami, Takahiro;
    • Yamasaki, Shintaro;
    • Johira, Yusuke;
    • Kosaka, Masanari;
    • Amioka, Kei;
    • Naruto, Kensuke;
    • Ando, Yuwa;
    • Yamaoka, Kenji;
    • Fujii, Yasutoshi;
    • Uchikawa, Shinsuke;
    • Fujino, Hatsue;
    • Ono, Atsushi;
    • Nakahara, Takashi;
    • Murakami, Eisuke;
    • Okamoto, Wataru;
    • Yamauchi, Masami;
    • Imamura, Michio
    Publication type:
    Article
    9

    Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma.

    Published in:
    Cancers, 2022, v. 14, n. 2, p. 320, doi. 10.3390/cancers14020320
    By:
    • Amioka, Kei;
    • Kawaoka, Tomokazu;
    • Kosaka, Masanari;
    • Johira, Yusuke;
    • Shirane, Yuki;
    • Miura, Ryoichi;
    • Murakami, Serami;
    • Yano, Shigeki;
    • Naruto, Kensuke;
    • Ando, Yuwa;
    • Kosaka, Yumi;
    • Fujii, Yasutoshi;
    • Kodama, Kenichiro;
    • Uchikawa, Shinsuke;
    • Fujino, Hatsue;
    • Ono, Atsushi;
    • Nakahara, Takashi;
    • Murakami, Eisuke;
    • Okamoto, Wataru;
    • Yamauchi, Masami
    Publication type:
    Article
    10

    Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice.

    Published in:
    Cancers, 2021, v. 13, n. 16, p. 3958, doi. 10.3390/cancers13163958
    By:
    • Ando, Yuwa;
    • Kawaoka, Tomokazu;
    • Kosaka, Masanari;
    • Shirane, Yuki;
    • Johira, Yusuke;
    • Miura, Ryoichi;
    • Murakami, Serami;
    • Yano, Shigeki;
    • Amioka, Kei;
    • Naruto, Kensuke;
    • Kosaka, Yumi;
    • Uchikawa, Shinsuke;
    • Kodama, Kenichiro;
    • Fujino, Hatsue;
    • Nakahara, Takashi;
    • Ono, Atsushi;
    • Murakami, Eisuke;
    • Yamauchi, Masami;
    • Okamoto, Wataru;
    • Takahashi, Shoichi
    Publication type:
    Article
    11
    12

    Successful Lenvatinib Re-challenge following Atezolizumab Plus Bevacizumab Combination Therapy Failure for Unresectable Hepatocellular Carcinoma.

    Published in:
    Internal Medicine, 2023, v. 62, n. 12, p. 1771, doi. 10.2169/internalmedicine.9581-22
    By:
    • Yumi Kosaka;
    • Tomokazu Kawaoka;
    • Masanari Kosaka;
    • Yuki Shirane;
    • Ryoichi Miura;
    • Serami Murakami;
    • Yusuke Johira;
    • Shigeki Yano;
    • Kei Amioka;
    • Kensuke Naruto;
    • Yuwa Ando;
    • Kenichiro Kodama;
    • Shinsuke Uchikawa;
    • Hatsue Fujino;
    • Atsushi Ohno;
    • Takashi Nakahara;
    • Eisuke Murakami;
    • Wataru Okamoto;
    • Masami Yamauchi;
    • Michio Imamura
    Publication type:
    Article
    13
    14
    15
    16
    17
    18

    Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology

    Published in:
    International Journal of Clinical Oncology, 2020, v. 25, n. 3, p. 403, doi. 10.1007/s10147-019-01610-y
    By:
    • Naito, Yoichi;
    • Mishima, Saori;
    • Akagi, Kiwamu;
    • Igarashi, Ataru;
    • Ikeda, Masafumi;
    • Okano, Susumu;
    • Kato, Shunsuke;
    • Takano, Tadao;
    • Tsuchihara, Katsuya;
    • Terashima, Keita;
    • Nishihara, Hiroshi;
    • Nishiyama, Hiroyki;
    • Hiyama, Eiso;
    • Hirasawa, Akira;
    • Hosoi, Hajime;
    • Maeda, Osamu;
    • Yatabe, Yasushi;
    • Okamoto, Wataru;
    • Ono, Shigeru;
    • Kajiyama, Hiroaki
    Publication type:
    Article
    19

    High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin.

    Published in:
    International Journal of Clinical Oncology, 2011, v. 16, n. 3, p. 244, doi. 10.1007/s10147-010-0170-6
    By:
    • Kidera, Yasuhiro;
    • Satoh, Taroh;
    • Ueda, Shinya;
    • Okamoto, Wataru;
    • Okamoto, Isamu;
    • Fumita, Soichi;
    • Yonesaka, Kimio;
    • Hayashi, Hidetoshi;
    • Makimura, Chihiro;
    • Okamoto, Kunio;
    • Kiyota, Hidemi;
    • Tsurutani, Junji;
    • Miyazaki, Masaki;
    • Yoshinaga, Masahiro;
    • Fujiwara, Kimiko;
    • Yamazoe, Yuzuru;
    • Moriyama, Kenzo;
    • Tsubaki, Masanobu;
    • Chiba, Yasutaka;
    • Nishida, Shozo
    Publication type:
    Article
    20

    Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 251, doi. 10.1159/000528145
    By:
    • Ando, Yuwa;
    • Kawaoka, Tomokazu;
    • Kosaka, Masanari;
    • Shirane, Yuki;
    • Johira, Yusuke;
    • Miura, Ryoichi;
    • Murakami, Serami;
    • Yano, Shigeki;
    • Amioka, Kei;
    • Naruto, Kensuke;
    • Kosaka, Yumi;
    • Uchikawa, Shinsuke;
    • Kodama, Kenichiro;
    • Fujino, Hatsue;
    • Nakahara, Takashi;
    • Ono, Atushi;
    • Murakami, Eisuke;
    • Yamauchi, Masami;
    • Okamoto, Wataru;
    • Takahashi, Shoichi
    Publication type:
    Article
    21
    22
    23
    24
    25

    The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma.

    Published in:
    International Journal of Cancer, 2022, v. 151, n. 12, p. 2278, doi. 10.1002/ijc.34247
    By:
    • Zhang, Peiyi;
    • Ono, Atsushi;
    • Fujii, Yasutoshi;
    • Hayes, Clair Nelson;
    • Tamura, Yosuke;
    • Miura, Ryoichi;
    • Shirane, Yuki;
    • Nakahara, Hikaru;
    • Yamauchi, Masami;
    • Uchikawa, Shinsuke;
    • Uchida, Takuro;
    • Teraoka, Yuji;
    • Fujino, Hatsue;
    • Nakahara, Takashi;
    • Murakami, Eisuke;
    • Miki, Daiki;
    • Kawaoka, Tomokazu;
    • Okamoto, Wataru;
    • Makokha, Grace Naswa;
    • Imamura, Michio
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32

    The Analysis of Muscle Volume Measured by Bioelectrical Impedance in Patients with Hepatocellular Carcinoma Treated with First-Line Atezolizumab plus Bevacizumab Combination Therapy or First-Line Lenvatinib.

    Published in:
    Oncology, 2023, v. 101, n. 8, p. 491, doi. 10.1159/000530991
    By:
    • Chihiro, Kikukawa;
    • Kawaoka, Tomokazu;
    • Uchikawa, Shinsuke;
    • Kinami, Takahiro;
    • Yamasaki, Shintaro;
    • Kosaka, Masanari;
    • Johira, Yusuke;
    • Yano, Shigeki;
    • Amioka, Kei;
    • Naruto, Kensuke;
    • Ando, Yuwa;
    • Yamaoka, Kenji;
    • Teraoka, Yuji;
    • Uchida, Takuro;
    • Fujino, Hatsue;
    • Nakahara, Takashi;
    • Ono, Atsushi;
    • Murakami, Eisuke;
    • Okamoto, Wataru;
    • Yamauchi, Masami
    Publication type:
    Article
    33
    34

    Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02016-3
    By:
    • Fujii, Yasutoshi;
    • Ono, Atsushi;
    • Hayes, C. Nelson;
    • Aikata, Hiroshi;
    • Yamauchi, Masami;
    • Uchikawa, Shinsuke;
    • Kodama, Kenichiro;
    • Teraoka, Yuji;
    • Fujino, Hatsue;
    • Nakahara, Takashi;
    • Murakami, Eisuke;
    • Miki, Daiki;
    • Okamoto, Wataru;
    • Kawaoka, Tomokazu;
    • Tsuge, Masataka;
    • Imamura, Michio;
    • Chayama, Kazuaki
    Publication type:
    Article
    35
    36
    37

    Efficacy and safety of chemoradiation therapy using one-shot cisplatin via hepatic arterial infusion for advanced hepatocellular carcinoma with major macrovascular invasion: a single-arm retrospective cohort study.

    Published in:
    2022
    By:
    • Naruto, Kensuke;
    • Kawaoka, Tomokazu;
    • Kodama, Kenichiro;
    • Ogawa, Yutaro;
    • Amioka, Kei;
    • Yoshikawa, Yuki;
    • Kikukawa, Chihiro;
    • Suehiro, Yousuke;
    • Yamaoka, Kenji;
    • Ando, Yuwa;
    • Kosaka, Yumi;
    • Uchikawa, Shinsuke;
    • Nakahara, Takashi;
    • Murakami, Eisuke;
    • Ono, Atsushi;
    • Uchida, Takuro;
    • Yamauchi, Masami;
    • Okamoto, Wataru;
    • Takahashi, Shoichi;
    • Imamura, Michio
    Publication type:
    journal article
    38

    Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors.

    Published in:
    2022
    By:
    • Yoshikawa, Yuki;
    • Imamura, Michio;
    • Yamauchi, Masami;
    • Hayes, C. Nelson;
    • Aikata, Hiroshi;
    • Okamoto, Wataru;
    • Miyata, Yoshihiro;
    • Okada, Morihito;
    • Hattori, Noboru;
    • Sugiyama, Kazuhiko;
    • Yoshioka, Yukio;
    • Toratani, Shigeaki;
    • Takechi, Masaaki;
    • Ichinohe, Tatsuo;
    • Ueda, Tsutomu;
    • Takeno, Sachio;
    • Kobayashi, Tsuyoshi;
    • Ohdan, Hideki;
    • Teishima, Jun;
    • Hide, Michihiro
    Publication type:
    journal article
    39
    40

    Impact of DNA integrity on the success rate of tissue‐based next‐generation sequencing: Lessons from nationwide cancer genome screening project SCRUM‐Japan GI‐SCREEN.

    Published in:
    Pathology International, 2020, v. 70, n. 12, p. 932, doi. 10.1111/pin.13029
    By:
    • Kuwata, Takeshi;
    • Wakabayashi, Masashi;
    • Hatanaka, Yutaka;
    • Morii, Eiichi;
    • Oda, Yoshinao;
    • Taguchi, Kenichi;
    • Noguchi, Masayuki;
    • Ishikawa, Yuichi;
    • Nakajima, Takashi;
    • Sekine, Shigeki;
    • Nomura, Shogo;
    • Okamoto, Wataru;
    • Fujii, Satoshi;
    • Yoshino, Takayuki
    Publication type:
    Article
    41

    The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment.

    Published in:
    PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0262675
    By:
    • Yamaoka, Kenji;
    • Kodama, Kenichiro;
    • Kawaoka, Tomokazu;
    • Kosaka, Masanari;
    • Johira, Yusuke;
    • Shirane, Yuki;
    • Miura, Ryoichi;
    • Yano, Shigeki;
    • Murakami, Serami;
    • Amioka, Kei;
    • Naruto, Kensuke;
    • Ando, Yuwa;
    • Kosaka, Yumi;
    • Uchikawa, Shinsuke;
    • Uchida, Takuro;
    • Fujino, Hatsue;
    • Nakahara, Takashi;
    • Murakami, Eisuke;
    • Okamoto, Wataru;
    • Yamauchi, Masami
    Publication type:
    Article
    42

    Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 5, p. 1, doi. 10.1002/cam4.7025
    By:
    • Kinami, Takahiro;
    • Uchikawa, Shinsuke;
    • Kawaoka, Tomokazu;
    • Yamasaki, Shintaro;
    • Kosaka, Masanari;
    • Johira, Yusuke;
    • Yano, Shigeki;
    • Amioka, Kei;
    • Naruto, Kensuke;
    • Yamaoka, Kenji;
    • Fujii, Yasutoshi;
    • Fujino, Hatsue;
    • Nakahara, Takashi;
    • Ono, Atsushi;
    • Murakami, Eisuke;
    • Okamoto, Wataru;
    • Yamauchi, Masami;
    • Miki, Daiki;
    • Tsuge, Masataka;
    • Oka, Shiro
    Publication type:
    Article
    43

    Correlation between serum pro‐inflammatory cytokine levels and the prognosis of the patients with acute liver failure.

    Published in:
    Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 9, p. 1637, doi. 10.1111/jgh.16300
    By:
    • Murakami, Serami;
    • Uchida, Takuro;
    • Imamura, Michio;
    • Suehiro, Yosuke;
    • Namba, Maiko;
    • Fujii, Yasutoshi;
    • Uchikawa, Shinsuke;
    • Teraoka, Yuji;
    • Fujino, Hatsue;
    • Ono, Atsushi;
    • Nakahara, Takashi;
    • Murakami, Eisuke;
    • Okamoto, Wataru;
    • Yamauchi, Masami;
    • Kawaoka, Tomokazu;
    • Miki, Daiki;
    • Hayes, C Nelson;
    • Tsuge, Masataka;
    • Ohira, Masahiro;
    • Ohdan, Hideki
    Publication type:
    Article
    44

    Phase II study of bi-weekly irinotecan for patients with previously treated HER2-negative metastatic breast cancer: KMBOG0610B.

    Published in:
    Breast Cancer (13406868), 2013, v. 20, n. 2, p. 131, doi. 10.1007/s12282-011-0316-z
    By:
    • Hayashi, Hidetoshi;
    • Tsurutani, Junji;
    • Satoh, Taro;
    • Masuda, Norikazu;
    • Okamoto, Wataru;
    • Morinaga, Ryotaro;
    • Terashima, Masaaki;
    • Miyazaki, Masaki;
    • Okamoto, Isamu;
    • Nishida, Yukihiro;
    • Tominaga, Shusei;
    • Tokunaga, Yukihiko;
    • Yamaguchi, Masahide;
    • Sakamoto, Junichi;
    • Nakayama, Takahiro;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    45
    46
    47

    A phase I/Ib study of trametinib (GSK1120212) alone and in combination with gemcitabine in Japanese patients with advanced solid tumors.

    Published in:
    Investigational New Drugs, 2015, v. 33, n. 5, p. 1058, doi. 10.1007/s10637-015-0270-2
    By:
    • Kasuga, Akiyoshi;
    • Nakagawa, Kazuhiko;
    • Nagashima, Fumio;
    • Shimizu, Toshio;
    • Naruge, Daisuke;
    • Nishina, Shinichi;
    • Kitamura, Hiroshi;
    • Kurata, Takayasu;
    • Takasu, Atsuko;
    • Fujisaka, Yasuhito;
    • Okamoto, Wataru;
    • Nishimura, Yuichiro;
    • Mukaiyama, Akihira;
    • Matsushita, Hideki;
    • Furuse, Junji
    Publication type:
    Article
    48
    49
    50